“Myocardial salvaging effects and mechanisms of dipeptidyl peptidase-IV inhibitor Vildagliptin in experimental diabetes”, Int Jour of Biomed Res, vol. 7, no. 5, pp. 276–282, May 2016, doi: 10.7439/ijbr.v7i5.3273.